{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T06:10:55Z","timestamp":1770358255918,"version":"3.49.0"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2017,6,15]],"date-time":"2017-06-15T00:00:00Z","timestamp":1497484800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["Fis PI15\/00506"],"award-info":[{"award-number":["Fis PI15\/00506"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008593","name":"European Respiratory Society","doi-asserted-by":"publisher","award":["ERS Long Term Fellowship"],"award-info":[{"award-number":["ERS Long Term Fellowship"]}],"id":[{"id":"10.13039\/100008593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008593","name":"European Respiratory Society","doi-asserted-by":"publisher","award":["ERS Long Term Fellowship"],"award-info":[{"award-number":["ERS Long Term Fellowship"]}],"id":[{"id":"10.13039\/100008593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008593","name":"European Respiratory Society","doi-asserted-by":"publisher","award":["ERS Short Term Fellowship"],"award-info":[{"award-number":["ERS Short Term Fellowship"]}],"id":[{"id":"10.13039\/100008593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0178022","type":"journal-article","created":{"date-parts":[[2017,6,15]],"date-time":"2017-06-15T16:48:04Z","timestamp":1497545284000},"page":"e0178022","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":28,"title":["Treatment with macrolides and glucocorticosteroids in severe community-acquired pneumonia: A post-hoc exploratory analysis of a randomized controlled trial"],"prefix":"10.1371","volume":"12","author":[{"given":"Adrian","family":"Ceccato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catia","family":"Cilloniz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Otavio T.","family":"Ranzani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosario","family":"Menendez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carles","family":"Agusti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Gabarrus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miquel","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oriol","family":"Sibila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael S.","family":"Niederman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5649-7699","authenticated-orcid":true,"given":"Antoni","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,6,15]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1001\/jama.1996.03530260048030","article-title":"Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis","volume":"275","author":"MJ Fine","year":"1996","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1378\/chest.07-1456","article-title":"A comparative study of community-acquired pneumonia patients admitted to the ward and the ICU","volume":"133","author":"MI Restrepo","year":"2008","journal-title":"Chest"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1097\/CCM.0b013e3182257445","article-title":"Inflammatory biomarkers and prediction for intensive care unit admission in severe community-acquired pneumonia","volume":"39","author":"P Ram\u00edrez","year":"2011","journal-title":"Crit Care Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/thx.2008.105312","article-title":"Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia","volume":"64","author":"R Men\u00e9ndez","year":"2009","journal-title":"Thorax"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1093\/cid\/civ686","article-title":"The Impact of Age on the Efficacy of 13-valent Pneumococcal Conjugate Vaccine in Elderly","volume":"61","author":"CH van Werkhoven","year":"2015","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.smim.2012.04.008","article-title":"Innate immunosenescence: effect of aging on cells and receptors of the innate immune system in humans","volume":"24","author":"R Solana","year":"2012","journal-title":"Semin Immunol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1111\/resp.12848","article-title":"Clinical features, aetiology and outcome of bacteraemic pneumonia in neutropenic cancer patients","volume":"21","author":"C Gudiol","year":"2016","journal-title":"Respirol Carlton Vic"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1164\/rccm.201211-2020OC","article-title":"Recombinant human activated protein C for adults with septic shock: a randomized controlled trial","volume":"187","author":"D Annane","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"ref9","first-page":"CD001090","article-title":"Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock","author":"MM Alejandria","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/cid\/cis414","article-title":"Macrolide-based regimens and mortality in hospitalized patients with community-acquired pneumonia: a systematic review and meta-analysis","volume":"55","author":"L Asadi","year":"2012","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1001\/jama.2014.4304","article-title":"Association of azithromycin with mortality and cardiovascular events among older patients hospitalized with pneumonia","volume":"311","author":"EM Mortensen","year":"2014","journal-title":"JAMA"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.2015.88","article-title":"Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial","volume":"313","author":"A Torres","year":"2015","journal-title":"JAMA"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0140-6736(14)62447-8","article-title":"Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial","volume":"385","author":"CA Blum","year":"2015","journal-title":"Lancet Lond Engl"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1378\/chest.15-1733","article-title":"Efficacy and Safety of Corticosteroids for Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis","volume":"149","author":"Y-D Wan","year":"2016","journal-title":"Chest"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1183\/09031936.00009208","article-title":"Effects of glucocorticoids in ventilated piglets with severe pneumonia","volume":"32","author":"O Sibila","year":"2008","journal-title":"Eur Respir J"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"519","DOI":"10.7326\/M15-0715","article-title":"Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia: A Systematic Review and Meta-analysis","volume":"163","author":"RAC Siemieniuk","year":"2015","journal-title":"Ann Intern Med"},{"key":"ref17","first-page":"67","article-title":"Immunomodulatory effects of macrolide antibiotics\u2014part 1: biological mechanisms","volume":"81","author":"J Altenburg","year":"2011","journal-title":"Respir Int Rev Thorac Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.rmed.2016.05.004","article-title":"Respiratory drugs and macrolides prevent asthma exacerbations: A real-world investigation","volume":"119","author":"A Arf\u00e8","year":"2016","journal-title":"Respir Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa1104623","article-title":"Azithromycin for prevention of exacerbations of COPD","volume":"365","author":"RK Albert","year":"2011","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jama.290.13.1749","article-title":"Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial","volume":"290","author":"L Saiman","year":"2003","journal-title":"JAMA"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S2213-2600(14)70213-9","article-title":"The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial","volume":"2","author":"GB Rogers","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"Suppl 2","key":"ref22","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"LA Mandell","year":"2007","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM199701233360402","article-title":"A prediction rule to identify low-risk patients with community-acquired pneumonia","volume":"336","author":"MJ Fine","year":"1997","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1164\/ajrccm.158.4.9803114","article-title":"Severe community-acquired pneumonia. Assessment of severity criteria","volume":"158","author":"S Ewig","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1001\/jama.279.18.1452","article-title":"Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines","volume":"279","author":"EA Halm","year":"1998","journal-title":"JAMA"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1183\/09031936.00040710","article-title":"Factors associated with inflammatory cytokine patterns in community-acquired pneumonia","volume":"37","author":"R Mart\u00ednez","year":"2011","journal-title":"Eur Respir J"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijantimicag.2007.08.001","article-title":"Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators","volume":"31","author":"EJ Giamarellos-Bourboulis","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1086\/591915","article-title":"The impact of steroids given with macrolide therapy on experimental Mycoplasma pneumoniae respiratory infection","volume":"198","author":"C Tagliabue","year":"2008","journal-title":"J Infect Dis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"L139","DOI":"10.1152\/ajplung.00292.2014","article-title":"Combination of erythromycin and dexamethasone improves corticosteroid sensitivity induced by CSE through inhibiting PI3K-\u03b4\/Akt pathway and increasing GR expression","volume":"309","author":"X-J Sun","year":"2015","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12931-015-0165-y","article-title":"Lung inflammatory pattern and antibiotic treatment in pneumonia","volume":"16","author":"M-J Lorenzo","year":"2015","journal-title":"Respir Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1183\/13993003.00474-2016","article-title":"Pathogen- and antibiotic-specific effects of prednisone in community-acquired pneumonia","volume":"48","author":"SA Wirz","year":"2016","journal-title":"Eur Respir J"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/jac\/dkr520","article-title":"Immunomodulatory effects of macrolides during community-acquired pneumonia: a literature review","volume":"67","author":"A Kovaleva","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 2","key":"ref33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s15010-005-8209-8","article-title":"Immunomodulatory activities of fluoroquinolones","volume":"33","author":"A Dalhoff","year":"2005","journal-title":"Infection"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1473-3099(03)00658-3","article-title":"Immunomodulatory effects of quinolones","volume":"3","author":"A Dalhoff","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/thx.2007.086785","article-title":"Markers of treatment failure in hospitalised community acquired pneumonia","volume":"63","author":"R Men\u00e9ndez","year":"2008","journal-title":"Thorax"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/thx.2003.017756","article-title":"Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome","volume":"59","author":"R Men\u00e9ndez","year":"2004","journal-title":"Thorax"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0178022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T22:20:48Z","timestamp":1540246848000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0178022"}},"subtitle":[],"editor":[{"given":"Pedro","family":"P\u00f3voa","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,6,15]]},"references-count":36,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0178022","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,15]]}}}